Doxycycline versus cephalexin treatment of presumed streptococcal skin and soft tissue infection among adults presenting to the emergency department
- PMID: 38169286
- PMCID: PMC10848771
- DOI: 10.1128/aac.01282-23
Doxycycline versus cephalexin treatment of presumed streptococcal skin and soft tissue infection among adults presenting to the emergency department
Abstract
Among 100 propensity score-matched emergency department patients receiving ≤14 days doxycycline versus cephalexin monotherapy for outpatient treatment of nonpurulent (presumed streptococcal) skin and soft tissue infection, a low rate of 14-day clinical failure was observed [6% each group; odds ratio (OR), 1.34 (0.21-8.69); P = 0.745], defined as hospital admission, i.v. antibiotic therapy, or change in oral antibiotic. Doxycycline may represent a reasonable therapeutic alternative for this indication in regions with low tetracycline resistance.
Keywords: Streptococcus pyogenes; cellulitis; emergency medicine; tetracyclines.
Conflict of interest statement
Dr. Nailor has served as a consultant for Shionogi, AbbVie, and Merck. All other authors declare no conflicts of interest.
Similar articles
-
Predictors of Oral Antibiotic Treatment Failure for Nonpurulent Skin and Soft Tissue Infections in the Emergency Department.Acad Emerg Med. 2019 Jan;26(1):51-59. doi: 10.1111/acem.13492. Epub 2018 Jul 4. Acad Emerg Med. 2019. PMID: 29869364
-
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.Pediatrics. 2009 Jun;123(6):e959-66. doi: 10.1542/peds.2008-2428. Epub 2009 May 26. Pediatrics. 2009. PMID: 19470525
-
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.Emerg Med J. 2018 Aug;35(8):492-498. doi: 10.1136/emermed-2017-207420. Epub 2018 Jun 18. Emerg Med J. 2018. PMID: 29914924
-
Hospitalist perspective on the treatment of skin and soft tissue infections.Mayo Clin Proc. 2014 Oct;89(10):1436-51. doi: 10.1016/j.mayocp.2014.04.018. Epub 2014 Jun 25. Mayo Clin Proc. 2014. PMID: 24974260 Review.
-
Evidence-based management of skin and soft-tissue infections in pediatric patients in the emergency department.Pediatr Emerg Med Pract. 2015 Feb;12(2):1-23; quiz 23-4. Pediatr Emerg Med Pract. 2015. PMID: 25682652 Review.
References
-
- Cairns C, Kang K. National hospital ambulatory medical care survey: 2020 emergency department summary tables. doi:10.15620/cdc:121911 - DOI
-
- Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. 2014. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59:147–159. doi:10.1093/cid/ciu296 - DOI - PubMed
-
- Centers for Disease Control and Prevention . Active bacterial core surveillance report, emerging infections program network, group A Streptococcus, 2019. Available from: www.cdc.gov/abcs/downloads/GAS_Surveillance_Report_2019.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
